Today is #WorldCancerDay!🎗️ Colorectal cancer is among the most common cancers worldwide. At SFB/TRR 417, we study the tumor microenvironment to improve CRC treatment. 👉 Visit LinkedIn for personal insights from our consortium! #TogetherAgainstColonCancer #UnitedByUnique worldcancerday.org

Save the Date: FRANKFURT CANCER CONFERENCE 2026 Translating Paul Ehrlich’s Magic Bullet into Novel Targeted Therapies 🕗 Wed., September 2, 2026 – Fri., September 4, 2026 📍Campus Westend, @goetheuni.bsky.social, Frankfurt/Main, DE ➡️ www.frankfurtcancerconference.org #frankfurtcancerconference

🚀 Strong start for our SFB/TRR 417, funded by @dfg.de! Our researchers from @goetheuni.bsky.social, @fau.de, @uni-freiburg.de, @pei.de and Georg-Speyer-Haus gathered to connect and exchange ideas on #ColorectalCancer and the #TumorMicroenvironment. Living up to our motto: #TogetherAgainstColonCancer

Great news: The #LOEWE Center Frankfurt Cancer Institute @goetheuni.bsky.social will continue to receive funding from the state of Hesse! 🎉 12 mio € for two more years – a strong signal for the importance of #translational #cancer #research in Frankfurt. Thank you Hesse and everyone involved!!

Im @loewe-fci.bsky.social arbeiten Forschende gemeinsam an translationaler #Krebsforschung. Nun wird das #FCI weiter vom Land Hessen gefördert: Wissenschaftsminister Timon Gremmels hat heute einen Förderbescheid für die Jahre 2026/27 überreicht. 🔗 Mehr: aktuelles.uni-frankfurt.de/allgemein/12...

🎉 Exciting news: my PhD project @daothilab.bsky.social has been published in #PLoS Pathogens! I investigated how the #hepatitis E virus ORF2 protein counteracts antiviral responses, contributing to persistent viral replication. A huge thank you to all collaborators! 🙏🏻 🔗 share.google/WwIT43Su3KOP...